Författare: Koraen Linn, Wahlberg Eric

Titel: ABC om claudicatio intermittens (serie: Medicinens ABC) 2010 nr 29 sid 1774-9

Läs/ladda hem artikeln:
Fullständig referenslista
Artikeln i pdf-format
Artikeln i webbversion
Sid 1774
Sid 1775
Sid 1776
Sid 1777
Sid 1778
Sid 1779
Om Läkartidningens fulltext på Internet

Sök liknande artiklar

1. Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Andersson B, Persson E, Wahlberg E. A population-based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences. J Vasc Surg. 2007 45;6;1185-91

2 . Hirsch A, Cirqui M, Treat-Jacobson D, Regensteiner JG, Creager MA, Olin JW et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001;286;1317-1324

3. Kemp GJ, Hands LJ, Ramaswami G, Taylor DJ, Nicolaides A, Amato A, Radda GK Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy. Clin Sci 1995;89;581-90

4. Palmer-Kazen U, Religa P, Wahlberg E. Exercise in patients with claudication elicits signs of inflammation and angiogenesis. Eur J Vasc Endovasc Surg. 2009 ;38;689-96

5. Abaci A, O_uzhan A, Kahraman S, Eryol NK, Unal S, Arinç H, Ergin A. Effect of diabetes mellitus on formation of coronary collateral vessels Circulation 1999;99;2239-41

6. De Vivo S, Palmer-Kazen U, Kahlin B, Wahlberg E. Risk factors for poor collateral formation in claudication. Vasc Endovasc Surgery 2005;39;519-24

7 . Jonasson T, Ringqvist I. Factors of prognostic importance for subsequent rest pain in patients with intermittent claudication. Acta Med Scand 1985;218;27-33

8. Cameron JD, Cruickshank JK. Glucose, insulin, diabetes and mechanisms of arterial dysfunction. Clin Exp Pharmacol Physiol. 2007 ;34(7):677-82

9. Sigvant B, Lundin F, Nilsson B, Bergqvist D, Wahlberg E. Intermittent Claudication is the same disease in men and women but differs in presentation. Society for Vascular Surgery, Denver, Colorado, USA, juni 2009. Abstract

10. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG. TASC II Inter Society consensus on peripheral arterial disease Eur J Vasc Endovasc Surg 2007;33;S1

1. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study Circulation 2004;109;733-39

2. Goss DE, de Trafford J, Roberts VC, Flynn MD, Edmonds ME, Watkins PJ, Raised ankle/brachial pressure index in insulin-treated diabetic patients, Diabet Med 1989;6; 576-8,

3. ATC Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients. B Med J 2002;324;71-86

4. ATC. Collaborative overview of randomised trials of antiplatelet therapy I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' collaboration. B Med J 1994;308;81-106.

5. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R et al; Prevention of Progression of Arterial Disease and Diabetes Study Group; Diabetes Registry Group; Royal College of Physicians Edinburgh.
B Med J. 2008;337:a1840. doi: 10.1136/bmj.a1840.

6. CAPRIE. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering committee. Lancet 1996;348;1329-1339

7. Bhatt D, Fox K, Hacke W, Berger PB, Black HR, Boden WE et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothromboic events. N Engl J Med 2006;354;1706-1717

8. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, Yusuf S. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110;1202-8

9. MRC/BHF Heart Protection Study of cholesterol lowering with Simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002 6;360(9326):7-22

20. Rapp JH. Basic data related to lipid abnormalities in peripheral vascular disease. Ann Vasc Surg. 1990;4;604-8

2 . 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25;1105-87

22. Paravash SC, Mendonca DA, DaSilva A. Beta-blockers for peripheral arterial disease. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD005508.

23. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR . UKPDS 59. Hyperglycemia and other potentially modifieable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25,894-9

24. Leng GC, Fowler BM, Ernst E. Exercise for intermittent claudication. Cochrane Databse of Systematic Reviews 2000, Issue 2. Art. No.:CD000990.DOI:10.1002/14651858.CD000990

25. Spronk S, Bosch, JL, den Hoed PT, Veen HF, Pattynama PM, Hunink MG. Intermittent claudication: Clinical effectiveness of endovascular revascularization versus supervised hospital based exercise training - Randomized controlled trial. Radiol. 2009;250;586-95

26. Oakley C, Zwierska J, Tew G, Beard JD, Saxton JM. Nordic poles immediately improve walking distance in patients with intermittent claudication Eur J Vasc Endovasc Surg. 2008;36;689-94

27. Thompson PD, Zimet R, Forbes WP, Zhang P. Meta-Analysis of Results from Eight Randomized, Placebo-Controlled Trials on the Effect of Cilostazol on Patients With Intermittent Claudication. Am J of Cardiol 2002;90;1314-19.

28. Hiatt W, Money SR, Brass EP. Long-Term Safety of Cilostazol in Patients with Peripheral Artery Disease: The CASTLE Study (Cilostazol: A Study in Long-term Effects). J Vasc Surg 2008; 47;330-6.

29. Swedvasc (Svenska Kärlregistret) http://www.ucr.uu.se/swedvasc/

30. Gelin J, Jivegård L, Taft C, Karlsson J, Sullivan M, Dahllöf AG et al. Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no rteatment in unselected randomised patients I: one year results of functional and physiological improvements. Eur J Vasc Endovasc Surg 2001;22;107-13

3 . Lundgren F, Dahllöf AG, Lundholm K, Schersten T, Volkmann R. Intermittent claudication - surgical reconstruction or physical training? A prospective randomized trial of treatment efficacy. Ann Surg 1989;209;346-55

32. Greenhalgh RM, Belch JJ, Brown LC, Gaines PA, Gao L, Reise JA et al. Mimic Trial Participants. The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease.Eur J Vasc Endovas Surg 2008;36;680-8

33. Ghosh R, Walsh SR, Tang TY, Noorani A, Hayes PD. Gene therapy as a novel therapeutic option in the treatment of peripheral vascular disease: systematic review and meta-analysis. Int J Clin Pract, 2008;62;1383-1390